| Modeling neurodegenerative diseases with cerebral organoids and other three-dimensional culture systems: focus on Alzheimer’s disease L Venkataraman, SR Fair, CA McElroy, ME Hester, H Fu Stem Cell Reviews and Reports, 1-22, 2020 | 42 | 2020 |
| Function of WFS1 and WFS2 in the Central Nervous System: Implications for Wolfram Syndrome and Alzheimer’s disease L Li, L Venkataraman, S Chen, H Fu Neuroscience & Biobehavioral Reviews 118, 775-783, 2020 | 28 | 2020 |
| Wolframin is a novel regulator of tau pathology and neurodegeneration S Chen, D Acosta, L Li, J Liang, Y Chang, C Wang, J Fitzgerald, ... Acta Neuropathologica 143 (5), 547-569, 2022 | 24 | 2022 |
| Novel atomic force microscopy based biopanning for isolation of morphology specific reagents against TDP-43 variants in amyotrophic lateral sclerosis SM Williams, L Venkataraman, H Tian, G Khan, BT Harris, MR Sierks JoVE (Journal of Visualized Experiments), e52584, 2015 | 16 | 2015 |
| Isolation and characterization of antibody fragment selective for human Alzheimer’s disease brain-derived tau variants L Venkataraman, P He, P Schulz, MR Sierks Neurobiology of Aging 94, 7-14, 2020 | 6 | 2020 |
| Isolation and characterization of antibody fragments selective for human FTD brain derived TDP-43 variants L Venkataraman, P He, G Khan, BT Harris, MR Sierks BMC Neuroscience 21 (1), 1-11, 2020 | 5 | 2020 |
| Sex-Specific Multiparameter Blood Test for the Early Diagnosis of Alzheimer’s Disease HJ Cho, P Schulz, L Venkataraman, RJ Caselli, MR Sierks International journal of molecular sciences 23 (24), 15670, 2022 | 4 | 2022 |
| Antibody based reagents that specifically recognize neurodegenerative disease related forms of the protein TDP-43 M Sierks, S Williams, L Venkataraman US Patent 10,191,068, 2019 | 2 | 2019 |
| Deficiency of WFS1 increases vulnerability to pathological tau in vitro and in vivo Molecular and cell biology/tau S Chen, L Venkaraman, J Liang, Y Nakano, NEH Villegas, C Brown, ... Alzheimer's & Dementia 16, e042085, 2020 | 1 | 2020 |
| Human alzheimer's disease and traumatic brain injury associated tau variants as biomarkers and methods of use thereof M Sierks, L Venkataraman, W Xin US Patent App. 16/060,880, 2019 | 1 | 2019 |
| Human alzheimer's disease and traumatic brain injury associated tau variants as biomarkers and methods of use thereof M Sierks, L Venkataraman, W Xin US Patent 11,549,113, 2023 | | 2023 |
| Antibody based reagents that specifically recognize neurodegenerative disease related forms of the protein tdp-43 M Sierks, S Williams, L Venkataraman US Patent App. 17/242,780, 2021 | | 2021 |
| Antibody based reagents that specifically recognize neurodegenerative disease related forms of the protein TDP-43 M Sierks, S Williams, L Venkataraman US Patent 11,022,618, 2021 | | 2021 |
| Antibody-Based Diagnostics and Therapeutics for Alzheimer's Disease and Frontotemporal Dementia L Venkataraman Arizona State University, 2018 | | 2018 |
| Microscopy Based Biopanning for Isolation of Morphology Specific Nanobodies against TDP-43 Variants in ALS and FTLD from Human Brain Tissues G Khan, S Williams, L Venkataraman, H Tian, M Sierks, B Harris JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 74 (6), 600-600, 2015 | | 2015 |
| Oligomeric amyloid-beta as a potential biomarker for Alzheimer's disease L Venkataraman Arizona State University, 2013 | | 2013 |
